Back to top
more

The Cooper Companies (COO)

(Real Time Quote from BATS)

$69.56 USD

69.56
1,381,568

-1.89 (-2.65%)

Updated Aug 5, 2025 03:44 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 24% (59 out of 246)

Industry: Medical - Dental Supplies

Zacks News

The Cooper Companies Inc (COO), based in Pleasanton, CA, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision (CVI) and CooperSurgical (CSI). CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company’s products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness. CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians. This strategic business unit has pursued a strategy of consolidation by acquiring critical treatment niches in a fragmented market.

Trina Mukherjee headshot

Coronavirus-Affected MedTech Drags S&P 500 Index Down

Amid uncertainty surrounding the coronavirus outbreak, here are a few S&P 500 MedTech stocks that took a hit.

Zacks Equity Research

Cooper Companies (COO) Misses on Q1 Earnings, Lifts View

Cooper Companies (COO) gains from core CVI segment in fiscal Q1.

Zacks Equity Research

Cooper Cos. (COO) Q1 Earnings and Revenues Miss Estimates

Cooper Cos. (COO) delivered earnings and revenue surprises of -0.74% and -0.26%, respectively, for the quarter ended January 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

What's in Store for Cooper Companies (COO) Q1 Earnings?

Cooper Companies (COO) fiscal first-quarter performance is likely to reflect better-than-expected performance at CVI and CSI, and higher revenues.

Zacks Equity Research

PCTEL (PCTI) to Report Q4 Earnings: What's in the Offing?

PCTEL's (PCTI) fourth-quarter performance is likely to have benefited from robust 5G scanning receiver business.

Zacks Equity Research

Ciena (CIEN) to Report Q1 Earnings: What's in the Offing?

Ciena's (CIEN) fiscal first-quarter performance is likely to have benefited from its global scale and diversification across geographies and customer segments.

Zacks Equity Research

Is a Beat in Store for ABM Industries' (ABM) Q1 Earnings?

ABM Industries' (ABM) first-quarter fiscal 2020 revenues are likely to have benefited from organic growth.

Zacks Equity Research

Analysts Estimate Cooper Cos. (COO) to Report a Decline in Earnings: What to Look Out for

Cooper Cos. (COO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Why Cooper Cos. (COO) is Poised to Beat Earnings Estimates Again

Cooper Cos. (COO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Sreyoshi Mukherjee headshot

Bleak Outlook for Medical Dental Supplies Industry

Despite digital dentistry and AI being dominant market trends, near-term prospects of the Dental industry look dull.

Zacks Equity Research

Cooper Cos. (COO) Up 3% Since Last Earnings Report: Can It Continue?

Cooper Cos. (COO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Cooper Cos. (COO) Q4 Earnings and Revenues Surpass Estimates

Cooper Cos. (COO) delivered earnings and revenue surprises of 0.92% and 0.91%, respectively, for the quarter ended October 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Domo (DOMO) to Report Q3 Earnings: What's in the Cards?

Domo's (DOMO) third-quarter fiscal 2020 results are expected to benefit from an expanding clientele and portfolio strength.

Zacks Equity Research

Okta (OKTA) to Report Q3 Earnings: What's in the Cards?

Okta's (OKTA) continued investments are expected to have kept third-quarter fiscal 2020 margin under pressure despite higher adoption of Identity solutions.

Zacks Equity Research

Factors to Consider Ahead of Guidewire's (GWRE) Q1 Earnings

Guidewire's (GWRE) Q1 results are expected to reflect gains from robust adoption of cloud-based InsurancePlatform suite of solutions. Rising expenditure on product enhancements might have been a drag.

Zacks Equity Research

Cooper Companies (COO) to Post Q4 Earnings: What's in Store?

Better-than-expected performance at CVI and CSI, and higher revenues are likely to have aided Cooper Companies (COO) in Q4 earnings.

Zacks Equity Research

What's in Store for Patterson Companies' (PDCO) Q2 Earnings?

Patterson Companies (PDCO) has likely gained from strength in Animal Health segment in the fiscal second quarter.

Zacks Equity Research

Coupa Software (COUP) to Post Q3 Earnings: What's in Store?

Coupa Software's (COUP) Q3 performance is likely to have gained from an expanding customer base, backed by sturdy adoption of Accelerate and virtual cards for POs.

Zacks Equity Research

Cooper Cos. (COO) Reports Next Week: Wall Street Expects Earnings Growth

Cooper Cos. (COO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Why Cooper Cos. (COO) is Poised to Beat Earnings Estimates Again

Cooper Cos. (COO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Equity Research

Cooper Companies' CVI Unit Gets FDA Nod, To Boost Eye Health

Cooper Companies' (COO) CVI Unit has receives FDA approval for its MiSight 1 day contact lens, which complements its commitment to eye health innovation.

Zacks Equity Research

Here's Why You Should Hold Cooper Companies (COO) Stock Now

Cooper Companies (COO) is gaining traction from expansion in international markets, robust product portfolio across segments and prudent acquisitions. However, forex continues to remain a concern.

Sreyoshi Mukherjee headshot

Dental Supplies Industry's Near-Term Outlook Looks Bright

With popular trends of digital dentistry and robotics gaining momentum, near-term prospects of the dental industry look promising.

Zacks Equity Research

Here's Why You Should Retain Cooper Companies (COO) Stock Now

Cooper Companies (COO) is gaining traction from expansion in international markets, robust product portfolio across segments and prudent acquisitions. However, forex continues to remain a concern.

Zacks Equity Research

Why Is Cooper Cos. (COO) Down 10.5% Since Last Earnings Report?

Cooper Cos. (COO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.